Among patients who were seronegative at baseline, or that they had not mounted a natural antibody response of their own, the antibody combination significantly reduced the primary outcome of 28-day mortality by one-fifth compared with usual care alone.from Top India News- News18.com https://www.news18.com/news/india/uk-trial-finds-regeneron-anti-viral-therapy-saves-lives-from-covid-19-3854360.html

No comments:
Post a Comment